Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intracoronary nicorandil before stent deployment in acute coronary syndrome undergoing PCI
ChiCTR1800019349Phase 4Completed
- Sponsor
- Qilu Hospital of Shandong University
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of nicorandil in acute coronary syndrome (ACS) (2 arms), sponsored by Qilu Hospital of Shandong University. Primary endpoints: soluble CD40 ligand, tumor necrosis factor alpha and 5 more. Started Mar 2016; status: completed.
02
Drugs
nicorandil
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on ChiCTR1800019349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800019349.